This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Cardiovascular

18
Boston Scientific announces CE mark for MRI labelling of EMBLEM™ S-ICD Systems
Boston Scientific announces CE mark for MRI labelling of EMBLEM™ S-ICD Systems
Read more
High Sensitive Troponin test first to measure impact of mental stress on the heart
High Sensitive Troponin test first to measure impact of mental stress on the heart
Read more
Hybrid Operating Theatres could lower costs and improve patient care
Hybrid Operating Theatres could lower costs and improve patient care
Read more
SMC accepts breakthrough treatment Entresto™ for symptomatic chronic heart failure
SMC accepts breakthrough treatment Entresto™ for symptomatic chronic heart failure
Read more
Global tech exclusivity boosts growth plans at Crawford Healthcare
Global tech exclusivity boosts growth plans at Crawford Healthcare
Read more
Polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe
Polymer-based, drug-eluting stent designed to treat peripheral lesions above the knee approved in Europe
Read more
Breakthrough drug for heart failure now available in the UK
Breakthrough drug for heart failure now available in the UK
Read more
Doctor wins award for work on treating patients with stab wounds
Doctor wins award for work on treating patients with stab wounds
Read more
Isansys wearable technology and wireless patient monitoring platform at Birmingham Children’s Hospital
Isansys wearable technology and wireless patient monitoring platform at Birmingham Children’s Hospital
Read more
Eluvia™ Drug-Eluting Vascular Stent System demonstrates 12-month primary patency of 96.1%
Eluvia™ Drug-Eluting Vascular Stent System demonstrates 12-month primary patency of 96.1%
Read more
Sanofi and Regeneron announce approval of Praluent® for the treatment of hypercholesterolaemia in the EU
Sanofi and Regeneron announce approval of Praluent® for the treatment of hypercholesterolaemia in the EU
Read more
Glasgow children first in Europe to benefit from technology enabling fewer invasive cardiac procedures
Glasgow children first in Europe to benefit from technology enabling fewer invasive cardiac procedures
Read more
New data confirm Tresiba® U200 delivers significantly lower rates of confirmed hypoglycaemia
New data confirm Tresiba® U200 delivers significantly lower rates of confirmed hypoglycaemia
Read more
New Xultophy® data show improvements in some patient reported outcomes versus glargine
New Xultophy® data show improvements in some patient reported outcomes versus glargine
Read more
LCZ696 to be available to the NHS under the Early Access to Medicines Scheme
LCZ696 to be available to the NHS under the Early Access to Medicines Scheme
Read more
New real-world evidence underscores low bleeding rates for Bayer’s Xarelto®
New real-world evidence underscores low bleeding rates for Bayer’s Xarelto®
Read more
LEADLESS II trial results confirm the positive benefits of the Nanostim leadless pacemaker
LEADLESS II trial results confirm the positive benefits of the Nanostim leadless pacemaker
Read more
Global atrial fibrillation registry presents two-year outcomes data
Global atrial fibrillation registry presents two-year outcomes data
Read more

Popular articles

Can plastic waste really be turned into sustainable paracetamol?
New DNA repair deficiency syndrome highlights need to tailor chemo regimens
Diagnostic AI tool ‘more accurate’ than physicians aims to ‘reshape’ healthcare
Be alert to Guillain-Barré risk after RSV vaccination in older adults, says MHRA
Forgo radioiodine ablation after thyroidectomy in low-risk cancer patients, say researchers



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x